BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
XYL
Xylem Inc.
XYL has the edge over BA overall, supported by stronger valuation and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
XYL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
XYL's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over XYL in the historical PE scenario, which offers more potential upside but is not a forecast.
XYL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $94.03 | — |
| Current | 21x | $94.03 | — |
| Cheap | 32x | $143 | +52% |
| Fair | 40x | $182 | +94% |
| Expensive | 62x | $278 | +196% |
Historical ranges are pointers, not guarantees.
XYL's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over XYL on the outlook, with more favorable revenue expectations.
XYL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect XYL's earnings to grow and its profitability to improve, with its revenue holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
XYL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.62 | +24% |
| Q3 2026 | $4.52 | +16% |
| Q2 2026 | $4.20 | +9.4% |
| Q1 2026 | $4.02 | +8.4% |
| Q4 2025 | $3.92 | +7.4% |
| Q3 2025 | $3.88 | +11% |
| Q2 2025 | $3.84 | +19% |
| Q1 2025 | $3.71 | +29% |
| Q4 2024 | $3.65 | +31% |
XYL has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over XYL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
XYL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | -3% |
| Q2 2026 | $2.3B | +1.5% |
| Q1 2026 | $2.1B | +2.7% |
| Q4 2025 | $2.4B | +6.3% |
| Q3 2025 | $2.3B | +7.8% |
| Q2 2025 | $2.3B | +6.1% |
| Q1 2025 | $2.1B | +1.8% |
| Q4 2024 | $2.3B | +6.5% |
XYL's revenue grew through 2024 and has held roughly level since: $2.2B last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.8 points |
| Q2 2026 | 17% | +3.4 points |
| Q1 2026 | 11% | +0.3 points |
| Q4 2025 | 15% | +2.9 points |
| Q3 2025 | 15% | +1.4 points |
| Q2 2025 | 13% | +1.6 points |
| Q1 2025 | 11% | +0.9 points |
| Q4 2024 | 12% | +1.9 points |
XYL has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over XYL on cash flow, with more consistent year-over-year improvement.
XYL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $242M | -14% |
| Q2 2026 | $201M | -2.9% |
| Q1 2026 | $18M | +$56M |
| Q4 2025 | $460M | -3.2% |
| Q3 2025 | $281M | +19% |
| Q2 2025 | $207M | -3.7% |
| Q1 2025 | -$38M | -353% |
| Q4 2024 | $475M | +32% |
XYL generated $921M in free cash flow over the past year, about the same as the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
XYL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
XYL has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
XYL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.6 | Neutral |
| Stochastic | 19.7 | Oversold |
XYL's weekly RSI is 35 (neutral) and its Stochastic is 20 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over XYL on valuation relative to its sector.
XYL PE vs Industrials Sector
| Metric | XYL | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 24x | 14% below |
| PE % | 0 | 58 | 58 pts below |
XYL is trading at 21x earnings, a 14% discount to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
XYL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.5 | 6.5% below |
| 20 week MA | $109.4 | 14% below |
| 50 week MA | $119.0 | 21% below |
| 100 week MA | $124.8 | 25% below |
| 200 week MA | $120.7 | 22% below |
XYL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over XYL on returns for 2026, with the stronger performance.
XYL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $78.8 | $100.3 | +27% |
| 2021 | $100.3 | $117.5 | +17% |
| 2022 | $117.5 | $109.7 | -6.6% |
| 2023 | $109.7 | $114.4 | +4.2% |
| 2024 | $114.4 | $117.5 | +2.8% |
| 2025 | $117.5 | $138.8 | +18% |
| 2026 YTD | $138.8 | $94.0 | -32% |
XYL is down 32% so far in 2026, after finishing higher in five of the previous six years.